Sales rise 7.50% to Rs 3223.30 crore
Net profit of Glenmark Pharmaceuticals rose 126.95% to Rs 340.27 crore in the quarter ended June 2024 as against Rs 149.93 crore during the previous quarter ended June 2023. Sales rose 7.50% to Rs 3223.30 crore in the quarter ended June 2024 as against Rs 2998.47 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales3223.302998.47 7 OPM %18.2514.59 -PBDT580.12345.46 68 PBT462.33203.42 127 NP340.27149.93 127Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
 "sensex nifty stock market share market")
 "Yere Goud and Vinay Kumar (L-R)")
 "Isro SSLV-D3 EOS-08 Mission")
 "Ajit Pawar, Ajit")
 "Pro Kabaddi League auction")
